Literature DB >> 18848602

Co-factors in liver disease: the role of HFE-related hereditary hemochromatosis and iron.

Daniel F Wallace1, V Nathan Subramaniam.   

Abstract

The severity of liver disease and its presentation is thought to be influenced by many host factors. Prominent among these factors is the level of iron in the body. The liver plays an important role in coordinating the regulation of iron homeostasis and is involved in regulating the level of iron absorption in the duodenum and iron recycling by the macrophages. Iron homeostasis is disturbed by several metabolic and genetic disorders, including various forms of hereditary hemochromatosis. This review will focus on liver disease and how it is affected by disordered iron homeostasis, as observed in hereditary hemochromatosis and due to HFE mutations. The types of liver disease covered herein are chronic hepatitis C virus (HCV) infection, alcoholic liver disease (ALD), non-alcoholic fatty liver disease (NAFLD), end-stage liver disease, hepatocellular carcinoma (HCC) and porphyria cutanea tarda (PCT).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848602     DOI: 10.1016/j.bbagen.2008.09.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin.

Authors:  Bryan D Maliken; William F Avrin; James E Nelson; Jody Mooney; Sankaran Kumar; Kris V Kowdley
Journal:  Ann Hepatol       Date:  2012 Jan-Feb       Impact factor: 2.400

Review 2.  Iron homeostasis and the inflammatory response.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

3.  Decreased prohepcidin levels in patients with HBV-related liver disease: relation with ferritin levels.

Authors:  Oya Yonal; Filiz Akyuz; Kadir Demir; Sevgi Ciftci; Fahriye Keskin; Binnur Pinarbasi; Ahmet Uyanikoglu; Halim Issever; Sadakat Ozdil; Gungor Boztas; Fatih Besisik; Sabahattin Kaymakoglu; Yilmaz Cakaloglu; Zeynel Mungan; Atilla Okten
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

Review 4.  Liver iron content determination by magnetic resonance imaging.

Authors:  Konstantinos Tziomalos; Vassilios Perifanis
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

5.  Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B.

Authors:  Chun-Yan Wang; Wei Lu; Dong-Sheng Hu; Guang-Dong Wang; Xiao-Jing Cheng
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 6.  Epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Franziska van Zijl; Gudrun Zulehner; Michaela Petz; Doris Schneller; Christoph Kornauth; Mara Hau; Georg Machat; Markus Grubinger; Heidemarie Huber; Wolfgang Mikulits
Journal:  Future Oncol       Date:  2009-10       Impact factor: 3.404

7.  Pathophysiology of NASH: perspectives for a targeted treatment.

Authors:  Fabio Marra; Sophie Lotersztajn
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 8.  Cutaneous manifestations of hepatitis C in the era of new antiviral agents.

Authors:  Simone Garcovich; Matteo Garcovich; Rodolfo Capizzi; Antonio Gasbarrini; Maria Assunta Zocco
Journal:  World J Hepatol       Date:  2015-11-28

Review 9.  Genetic mechanisms and modifying factors in hereditary hemochromatosis.

Authors:  Günter Weiss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11-17       Impact factor: 46.802

10.  Lymphocyte subsets in alcoholic liver disease.

Authors:  Luís Costa Matos; Paulo Batista; Nuno Monteiro; João Ribeiro; Maria A Cipriano; Pedro Henriques; Fernando Girão; Armando Carvalho
Journal:  World J Hepatol       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.